Search research articles
Contact Us
Filters
Showing results (171-180 of 316) with videos related to
Page
of 32
Sort By:
Muscle & Nerve
|
April 30, 2004
Absence of sensory neuropathy among workers with occupational exposure to chlorpyrifos
James W Albers, David H Garabrant, Sarah Schweitzer, et al.
BMC Health Services Research
|
October 23, 2009
Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda
Joseph B Babigumira, Barbara Castelnuovo, Mohammed Lamorde, et al.
Nature Structural Biology
|
March 1, 1997
Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins
C Brenner, P Garrison, J Gilmour, et al.
Journal of Medical Economics
|
March 26, 2010
The economic value of reducing medication dosing frequency with drug delivery technologies: an evidence assessment
Mindy M Cheng, Rafael Alfonso, Jennie H Best, et al.
Urology
|
May 4, 2013
Renal rhabdomyosarcoma in a pancake kidney
Ashley Walther, Nicholas G Cost, Aaron P Garrison, et al.
Scientific Reports
|
May 15, 2023
Critically endangered Rice's whales (Balaenoptera ricei) selectively feed on high-quality prey in the Gulf of Mexico
Jeremy J Kiszka, Michelle Caputo, Johanna Vollenweider, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2008
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model
Beate Sander, Azhar Nizam, Louis P Garrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 21, 2015
The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer
Louis P Garrison, Joseph B Babigumira, Anthony Masaquel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 28, 2021
Modeling the Ex Post Real Option Value in Metastatic Melanoma Using Real-World Data
Woojung Lee, Meng Li, William B Wong, et al.
Journal of Medical Economics
|
May 4, 2019
Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study
Gregory F Guzauskas, Erqi L Pollom, Volker W Stieber, et al.
Page
of 32
Search research articles
Search
Showing results (171-180 of 316) with videos related to
Sort By:
Page
of 32
Muscle & Nerve
|
April 30, 2004
Absence of sensory neuropathy among workers with occupational exposure to chlorpyrifos
James W Albers, David H Garabrant, Sarah Schweitzer, et al.
BMC Health Services Research
|
October 23, 2009
Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda
Joseph B Babigumira, Barbara Castelnuovo, Mohammed Lamorde, et al.
Nature Structural Biology
|
March 1, 1997
Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins
C Brenner, P Garrison, J Gilmour, et al.
Journal of Medical Economics
|
March 26, 2010
The economic value of reducing medication dosing frequency with drug delivery technologies: an evidence assessment
Mindy M Cheng, Rafael Alfonso, Jennie H Best, et al.
Urology
|
May 4, 2013
Renal rhabdomyosarcoma in a pancake kidney
Ashley Walther, Nicholas G Cost, Aaron P Garrison, et al.
Scientific Reports
|
May 15, 2023
Critically endangered Rice's whales (Balaenoptera ricei) selectively feed on high-quality prey in the Gulf of Mexico
Jeremy J Kiszka, Michelle Caputo, Johanna Vollenweider, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2008
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model
Beate Sander, Azhar Nizam, Louis P Garrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 21, 2015
The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer
Louis P Garrison, Joseph B Babigumira, Anthony Masaquel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 28, 2021
Modeling the Ex Post Real Option Value in Metastatic Melanoma Using Real-World Data
Woojung Lee, Meng Li, William B Wong, et al.
Journal of Medical Economics
|
May 4, 2019
Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study
Gregory F Guzauskas, Erqi L Pollom, Volker W Stieber, et al.
Page
of 32